Introduction

BlueGene/L doubles up

March 24th, 2005

Some people may think the US is losing ground in science and technology, but for the time being at least, it’s still setting the pace in supercomputing. BlueGene/L, which was already number one on the latest Top 500, nearly doubled its performance after doubling its processor count. Back in mid-February, truckloads of components began arriving at Lawrence Livermore National Laboratory (LLNL), which operates the IBM built system for the Department of Energy and the National Nuclear Security Administration (NNSA), and the folks at LLNL added another 32,000 processors to the equal number already installed. Well, the early results are in. Roughly as expected, BlueGene/L can now crank away at 135.3 trillion floating point operations per second (teraflops), up from the 70.72 teraflops it was doing at the end of 2004. BlueGene/L now has half of its planned processors and is more than half way to achieving its design goal of 360 teraflops.

[CORRECTION] In the last sentence above, we mistakenly said that BlueGene/L “is more than half way to achieving its design goal of 360 teraflops.” Thanks for pointing out our error and thanks for the comments.

The moderators and/or administrators of this weblog reserve the right to edit or delete ANY content that appears on the site. In other words, the moderators and administrators have complete discretion over the removal of any content deemed by them to be inappropriate, in full or in part.

Any opinions expressed on this site belong to their respective authors and are not necessarily shared by the sponsoring institutions or the National Science Foundation.

Any trademarks or trade names, registered or otherwise, that appear on this site are the property of their respective owners and, unless noted, do not represent endorsement by the editors, publishers, sponsoring institutions, the National Science Foundation, or any other member of the CTWatch team.

No guarantee is granted by CTWatch that information appearing in the Blog is complete or accurate. Information on this site is not intended for commercial purposes.